BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15985208)

  • 1. [Semaphorins and cancers : an up 'dating'].
    Nasarre P; Constantin B; Drabkin HA; Roche J
    Med Sci (Paris); 2005; 21(6-7):641-7. PubMed ID: 15985208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent deletion of 3p21.1 region carrying semaphorin 3G and aberrant expression of the genes participating in semaphorin signaling in the epithelioid type of malignant mesothelioma cells.
    Yoshikawa Y; Sato A; Tsujimura T; Morinaga T; Fukuoka K; Yamada S; Murakami A; Kondo N; Matsumoto S; Okumura Y; Tanaka F; Hasegawa S; Hashimoto-Tamaoki T; Nakano T
    Int J Oncol; 2011 Dec; 39(6):1365-74. PubMed ID: 21842119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
    Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
    Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endothelial and tumor cells with semaphorins.
    Bielenberg DR; Klagsbrun M
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):421-31. PubMed ID: 17768598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
    Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
    Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class 3 semaphorin in angiogenesis and lymphangiogenesis.
    Bussolino F; Giraudo E; Serini G
    Chem Immunol Allergy; 2014; 99():71-88. PubMed ID: 24217603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Jun; 63(12):3352-5. PubMed ID: 12810670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.
    Capparuccia L; Tamagnone L
    J Cell Sci; 2009 Jun; 122(Pt 11):1723-36. PubMed ID: 19461072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent inactivation of RASSF1A, BLU, and SEMA3B on 3p21.3 by promoter hypermethylation and allele loss in non-small cell lung cancer.
    Ito M; Ito G; Kondo M; Uchiyama M; Fukui T; Mori S; Yoshioka H; Ueda Y; Shimokata K; Sekido Y
    Cancer Lett; 2005 Jul; 225(1):131-9. PubMed ID: 15922865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line.
    Tse C; Xiang RH; Bracht T; Naylor SL
    Cancer Res; 2002 Jan; 62(2):542-6. PubMed ID: 11809707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class 3 semaphorins and their receptors in physiological and pathological angiogenesis.
    Staton CA
    Biochem Soc Trans; 2011 Dec; 39(6):1565-70. PubMed ID: 22103488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class 3 semaphorins as a therapeutic target.
    Goshima Y; Sasaki Y; Yamashita N; Nakamura F
    Expert Opin Ther Targets; 2012 Sep; 16(9):933-44. PubMed ID: 22834859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.
    Tomizawa Y; Sekido Y; Kondo M; Gao B; Yokota J; Roche J; Drabkin H; Lerman MI; Gazdar AF; Minna JD
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13954-9. PubMed ID: 11717452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The semaphorins and their receptors as modulators of tumor progression.
    Neufeld G; Mumblat Y; Smolkin T; Toledano S; Nir-Zvi I; Ziv K; Kessler O
    Drug Resist Updat; 2016 Nov; 29():1-12. PubMed ID: 27912840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.
    Joseph D; Ho SM; Syed V
    Mol Cancer Ther; 2010 Feb; 9(2):499-509. PubMed ID: 20124444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
    Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
    Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Semaphorin and neuropilin expression during early morphogenesis of Xenopus laevis.
    Koestner U; Shnitsar I; Linnemannstöns K; Hufton AL; Borchers A
    Dev Dyn; 2008 Dec; 237(12):3853-63. PubMed ID: 18985750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases.
    Varshavsky A; Kessler O; Abramovitch S; Kigel B; Zaffryar S; Akiri G; Neufeld G
    Cancer Res; 2008 Sep; 68(17):6922-31. PubMed ID: 18757406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells.
    Kigel B; Varshavsky A; Kessler O; Neufeld G
    PLoS One; 2008 Sep; 3(9):e3287. PubMed ID: 18818766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis.
    Moriya J; Minamino T; Tateno K; Okada S; Uemura A; Shimizu I; Yokoyama M; Nojima A; Okada M; Koga H; Komuro I
    Circ Res; 2010 Feb; 106(2):391-8. PubMed ID: 19940264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.